2024-09-30 - Analysis Report
## Thermo Fisher Scientific Inc. (TMO) Stock Analysis:

**Company Overview:** Thermo Fisher Scientific Inc. is a leading provider of scientific instruments, consumables, software, and services for research, analysis, and diagnostics.

**1. Performance Analysis:**

* **Cumulative Return:** TMO has generated a cumulative return of 254.4%, significantly outperforming the S&P 500 (VOO) with a cumulative return of 133.28%. 
* **Relative Performance:** This indicates that TMO has significantly outperformed the market. Its relative performance is 55.8% compared to the S&P 500, meaning its performance falls within the 55.8th percentile of its historical performance range.
* **Divergence:**  The current divergence from the S&P 500 (121.12) is substantial, suggesting TMO has been consistently outperforming the broader market.

**2. Recent Price Movement:**

* **Closing Price:** 618.22
* **5-day Moving Average:** 611.62
* **20-day Moving Average:** 613.32
* **60-day Moving Average:** 594.29

The stock price is currently trading slightly above its short-term moving averages (5 and 20-day), indicating positive momentum. The 60-day moving average is lower than the current price, suggesting potential for further upward movement.

**3. Technical Indicators:**

* **RSI:** 48.51. This suggests the stock is currently trading in a neutral territory, neither overbought nor oversold.
* **PPO:** -0.13. A negative PPO indicates a bearish signal, suggesting potential for a downward correction in the short term.
* **Delta_Previous_Relative_Divergence:** -1.03. The negative value suggests a short-term downtrend in relative performance compared to the previous period.
* **Expected Return:** 19.46%. This indicates a potential for high returns over the next five years if you invest in TMO.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-02 | 4.05 | 10.54 B$ |
| 2024-05-03 | 3.47 | 10.35 B$ |
| 2023-11-03 | 4.44 | 10.57 B$ |
| 2023-08-04 | 3.53 | 10.69 B$ |
| 2024-08-02 | 3.53 | 10.69 B$ |

The most recent earnings report (2024-08-02) showed an EPS of 4.05, exceeding analysts' estimates. Revenue also beat expectations. The company's consistent revenue growth and solid earnings performance demonstrate its resilience and strong market position.

**5. News and Recent Issues:**

* **Recent Market Outlook:**  Thermo Fisher Scientific continues to benefit from strong demand for its products, especially in the life sciences and diagnostics segments. The company's focus on innovation, acquisitions, and expansion into emerging markets is driving its growth. 
* **Analyst Opinions and Performance Highlights:**  Analysts are generally optimistic about TMO's future prospects, citing the company's strong fundamentals and growth opportunities.  
* **FINBOLD insights:** The company's recent acquisition of PPD, a leading contract research organization (CRO), is expected to further strengthen its position in the clinical research market. 

**6. Overall Analysis:**

Thermo Fisher Scientific Inc. (TMO) is a strong performer with a robust track record of outperforming the market. The company is well-positioned to benefit from long-term growth trends in the healthcare and life sciences sectors. While the technical indicators suggest potential for a short-term correction, the company's strong fundamentals and positive market outlook suggest long-term growth potential. Investors considering adding TMO to their portfolio should carefully monitor its short-term price movements and consider its long-term growth prospects.

**7. Disclaimer:** This analysis is for informational purposes only and should not be considered financial advice. Investing in the stock market always involves risks, and it is crucial to conduct your own due diligence before making any investment decisions. 
